Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
SNTA [NASD]
Synta Pharmaceuticals Corp.
Index- P/E- EPS (ttm)-1.25 Insider Own4.50% Shs Outstand93.28M Perf Week-2.91%
Market Cap374.05M Forward P/E- EPS next Y-1.11 Insider Trans44.32% Shs Float56.86M Perf Month-1.96%
Income-93.00M PEG- EPS next Q-0.27 Inst Own23.10% Short Float21.69% Perf Quarter-4.75%
Sales- P/S- EPS this Y-19.80% Inst Trans0.32% Short Ratio7.86 Perf Half Y-23.47%
Book/sh0.45 P/B8.91 EPS next Y-1.80% ROA-120.90% Target Price12.70 Perf Year-41.12%
Cash/sh0.84 P/C4.75 EPS next 5Y0.00% ROE-271.20% 52W Range3.70 - 7.30 Perf YTD-23.47%
Dividend- P/FCF- EPS past 5Y14.30% ROI- 52W High-45.75% Beta2.59
Dividend %- Quick Ratio2.50 Sales past 5Y- Gross Margin- 52W Low7.03% ATR0.16
Employees134 Current Ratio2.50 Sales Q/Q- Oper. Margin- RSI (14)39.46 Volatility2.36% 4.13%
OptionableYes Debt/Eq0.55 EPS Q/Q6.70% Profit Margin- Rel Volume0.69 Prev Close4.01
ShortableYes LT Debt/Eq0.30 EarningsMay 08 BMO Payout- Avg Volume1.57M Price3.96
Recom2.70 SMA20-6.71% SMA50-6.05% SMA200-18.57% Volume638,516 Change-1.25%
13-Mar-14Reiterated MLV & Co Buy $10 → $6
12-Mar-14Downgrade Stifel Hold → Sell
05-Nov-13Reiterated MLV & Co Buy $16 → $10
06-Jun-13Reiterated MLV & Co Buy $18.50 → $16
01-Apr-13Reiterated MLV & Co Buy $16 → $18.50
30-Aug-12Initiated Stifel Nicolaus Hold
05-Jan-12Initiated Rodman & Renshaw Mkt Outperform $8
14-Mar-11Reiterated Barclays Capital Equal Weight $2 → $4
28-Feb-11Upgrade Canaccord Genuity Hold → Buy $4.50 → $8
09-Nov-10Initiated MLV Capital Buy $8.50
26-Aug-10Initiated Morgan Joseph Buy $6
10-May-10Upgrade Roth Capital Hold → Buy $4
19-Feb-10Initiated RBC Capital Mkts Sector Perform $5
17-Feb-10Downgrade Roth Capital Buy → Hold $4
05-Nov-09Upgrade Roth Capital Hold → Buy $2 → $4
27-Feb-09Downgrade Wachovia Mkt Perform → Underperform
27-Feb-09Downgrade Roth Capital Buy → Hold $11 → $2
27-Feb-09Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
27-Feb-09Downgrade RBC Capital Mkts Outperform → Sector Perform
27-Feb-09Downgrade Lazard Capital Buy → Hold
30-Jul-14 08:00AM  Synta to Host Conference Call and Webcast of Second Quarter 2014 Financial Results on August 6, 2014 Business Wire
22-Jul-14 09:07AM  Synta Pharmaceuticals data positive, says JMP Securities at theflyonthewall.com
21-Jul-14 05:07PM  SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
04:30PM  Synta Announces Advancement of Ganetespib into Phase 3 Extension of AML LI-1 Study for Patients with AML and High-Risk MDS Business Wire
18-Jul-14 04:16PM  SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material EDGAR Online
08-Jul-14 06:54AM  Synta Pharmaceuticals (SNTA) Shares March Higher, Can It Continue? Zacks
07-Jul-14 06:40AM  Synta Pharmaceuticals (SNTA) Jumps: Stock Rises 7.9% Zacks +5.33%
27-Jun-14 04:23PM  SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
04:23PM  SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Change in Directors or Principal Officers
24-Jun-14 02:31PM  Synta Pharmaceuticals mentioned positively by The Street contributor at theflyonthewall.com -5.16%
02:31PM  Synta Pharmaceuticals mentioned positively by The Street contributor
02:22PM  A Beaten-Down Biotech Stock Gearing Up for a Big Squeeze Higher at TheStreet
02:22PM  A Beaten-Down Biotech Stock Gearing Up for a Big Squeeze Higher
19-Jun-14 04:01PM  Synta to Present at the 9th Annual JMP Securities Healthcare Conference Business Wire
04:01PM  Synta to Present at the 9th Annual JMP Securities Healthcare Conference
18-Jun-14 03:26PM  5-Star Biotech Stock Watch: Synta Pharmaceuticals Benzinga
03:26PM  5-Star Biotech Stock Watch: Synta Pharmaceuticals
17-Jun-14 04:14PM  SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
04:14PM  SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
16-Jun-14 02:27PM  3 Biotech Stocks Backed By Big Money Benzinga
10:00AM  Why A Short Covering Rally Might Come for Synta (SNTA) Stock Zacks
10:00AM  Why A Short Covering Rally Might Come for Synta (SNTA) Stock
08:47AM  Five Biotech Stocks With Big Potential And Billionaire Believers at Forbes
08:47AM  Five Biotech Stocks With Big Potential And Billionaire Believers
29-May-14 08:00AM  Synta to Present at the Jefferies 2014 Global Healthcare Conference Business Wire
08:00AM  Synta to Present at the Jefferies 2014 Global Healthcare Conference
28-May-14 08:00AM  Synta Announces Presentations at the 2014 American Society for Clinical Oncology (ASCO) Annual Meeting Business Wire
08:00AM  Synta Announces Presentations at the 2014 American Society for Clinical Oncology (ASCO) Annual Meeting
23-May-14 07:58AM  Short Interest is Piling Up in Synta (SNTA) Stock, Time to Panic? Zacks
07:58AM  Short Interest is Piling Up in Synta (SNTA) Stock, Time to Panic?
16-May-14 01:04PM  SYNTA PHARMACEUTICALS CORP Financials EDGAR Online Financials
01:04PM  SYNTA PHARMACEUTICALS CORP Financials
08-May-14 01:57PM  5 Stocks Under $10 Set to Soar at TheStreet
01:57PM  5 Stocks Under $10 Set to Soar
01:48PM  Synta's Loss Widens 14% As It Reports Its Final Analysis From the GALAXY-1 Trial at Motley Fool
11:22AM  SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
10:00AM  Synta Pharmaceuticals Corp. Earnings Call scheduled for 10:00 am ET today CCBN
09:50AM  Synta Pharmaceuticals Corp. Earnings Call scheduled for 10:00 am ET today CCBN
07:34AM  Synta Pharmaceuticals Corp. Earnings Call scheduled for 10:00 am ET today CCBN
07:18AM  Synta announces final analysis of GALAXY-1 ganetespib trial results theflyonthewall.com
07:18AM  Synta announces final analysis of GALAXY-1 ganetespib trial results at theflyonthewall.com
07:15AM  Synta sees cash resources 'sufficient' to fund operations into 1H15 theflyonthewall.com
07:15AM  Synta sees cash resources 'sufficient' to fund operations into 1H15 at theflyonthewall.com
07:14AM  Synta Pharmaceuticals reports Q1 EPS 28c, consensus 29c at theflyonthewall.com
07:07AM  Q1 2014 Synta Pharmaceuticals Corp. Earnings Release - Before Market Open CCBN
07:01AM  Synta Reports First Quarter 2014 Financial Results and Provides Corporate Update Business Wire
07:00AM  Synta Announces Results From Final Analysis of the GALAXY-1 Trial of Ganetespib in NSCLC Business Wire
06:11AM  SYNTA PHARMACEUTICALS CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
29-Apr-14 05:00PM  Synta to Host Conference Call and Webcast of First Quarter 2014 Financial Results on May 8, 2013 Business Wire
28-Apr-14 03:26PM  Novel Oncology Treatments Turn Stage 4 Cancer into Chronic Disease State: Citigroup Investment Global Head of Healthcare Research & Analysis Andrew Baum, M.D. Interviews with the Wall Street Transcript Wall Street Transcript
21-Apr-14 10:12AM  Speculative But Attractive Biotechs Insiders Are Buying at Seeking Alpha
15-Apr-14 10:43AM  Stocks: Insiders Buy at Opko Health and Conn's at Minyanville
10:43AM  Stocks: Insiders Buy at Opko Health and Conn's Inc. at Minyanville
14-Apr-14 08:37AM  SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial St EDGAR Online
08:00AM  Synta Pharmaceuticals Enters Into Agreement to Sell $5.0 Million in Common Stock Directly to an Affiliate of Synta Board Member Bruce Kovner Business Wire
07-Apr-14 07:30AM  Synta Announces Presentations at the 2014 Annual Meeting of the American Association of Cancer Research Business Wire
21-Mar-14 09:27AM  Synta Pharmaceuticals weakness overdone, says Roth Capital at theflyonthewall.com
05:44AM  Synta Pharmaceuticals Corp. (SNTA) Catches Eye: Stock Jumps 9.5% Zacks
20-Mar-14 08:02PM  Why Synta Pharmaceuticals, Herman Miller, and Tower Semiconductor Jumped Today at Motley Fool +9.47%
04:31PM  SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Sta EDGAR Online
02:34PM  Why Synta Pharmaceuticals Corp. Shares Soared at Motley Fool
05:45AM  Synta Announces Positive Interim Results from the ENCHANT-1 Trial of Ganetespib in Metastatic Breast Cancer at the 9th European Breast Cancer Conference Business Wire
19-Mar-14 08:50PM  Pharma Firms in Focus and Other #Stocks2Watch at Fox Business
14-Mar-14 01:04PM  SYNTA PHARMACEUTICALS CORP Financials EDGAR Online Financials
12-Mar-14 11:47AM  Why Synta Pharmaceuticals Corp. Plunged Today at Motley Fool -13.83%
11:47AM  Why Synta Pharmaceuticals Corp. Plunged Today
06:52AM  Synta Pharma downgraded by Stifel Briefing.com
11-Mar-14 02:55PM  Why Synta Pharmaceuticals Corp. Shares Jumped at Motley Fool
02:55PM  Why Synta Pharmaceuticals Corp. Shares Jumped
02:01PM  Synta Pharmaceuticals' Management Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
02:01PM  Synta Pharmaceuticals' Management Discusses Q4 2013 Results - Earnings Call Transcript
10:00AM  Synta Pharmaceuticals Corp. Earnings Call scheduled for 10:00 am ET today CCBN
09:55AM  Synta Pharmaceuticals Corp. Discusses Q3 2013 Results (Webcast) at Seeking Alpha
09:55AM  Synta Pharmaceuticals Corp. Discusses Q3 2013 Results (Webcast)
07:07AM  Q4 2013 Synta Pharmaceuticals Corp. Earnings Release - Before Market Open CCBN
07:04AM  Synta Reports Fourth Quarter and Year-End 2013 Financial Results and Provides Corporate Update Business Wire
07:04AM  Synta Reports Fourth Quarter and Year-End 2013 Financial Results and Provides Corporate Update
07:02AM  Synta and QuantumLeap Healthcare Collaborative Announce Selection of Ganetespib for I-SPY 2 TRIAL in Breast Cancer Business Wire
07:02AM  Synta and QuantumLeap Healthcare Collaborative Announce Selection of Ganetespib for I-SPY 2 TRIAL in Breast Cancer
06:06AM  SYNTA PHARMACEUTICALS CORP Files SEC form 10-K, Annual Report EDGAR Online
06-Mar-14 06:46AM  Weakness Seen in Synta Pharmaceuticals (SNTA): Stock Tumbles 13.5% Zacks
04-Mar-14 05:01PM  SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Other Events EDGAR Online
09:33AM  Synta Pharma CEO Sudden Resignation Might Trigger Overhaul at TheStreet
09:12AM  On The Fly: Pre-market Movers at theflyonthewall.com
08:30AM  SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Sta EDGAR Online
03-Mar-14 05:51PM  Synta CEO Bahcall Resigns as Board Panel to Run Drugmaker at Bloomberg
04:01PM  Synta Announces Executive Management Changes, Appoints Dr. Paul A. Friedman Director Business Wire
28-Feb-14 01:35PM  Synta to Present on Hsp90-inhibitor Drug Conjugate Platform at the 12th International Congress on Targeted Anticancer Therapies Business Wire -6.36%
27-Feb-14 04:05PM  Synta to Present at Upcoming Conferences Business Wire
26-Feb-14 04:05PM  Synta to Host Conference Call and Webcast of Fourth Quarter and Year-End 2013 Financial Results on March 11, 2014 Business Wire
25-Feb-14 06:41AM  Synta Pharmaceuticals (SNTA) Catches Eye: Stock Rises 8.9% Zacks
24-Feb-14 07:30AM  Synta Reports on Progress with Lead HDC Compounds at IASLC Conference Business Wire +8.85%
18-Feb-14 08:30AM  Synta Announces Upcoming Oral Presentations on Hsp90-Inhibitor Drug Conjugate (HDC) Platform Business Wire
10-Feb-14 10:22AM  Heres Why Synta Is a Good Play in the Cancer Meds Market at Wall St. Cheat Sheet +11.52%
03-Feb-14 05:36AM  Should You Worry About the Short Interest in Synta Pharmaceuticals (SNTA)? Zacks -6.74%
05:36AM  Should You Worry About the Short Interest in Synta Pharmaceuticals (SNTA)?
27-Jan-14 09:04AM  Synta Pharmaceuticals provides update on Q4 operations and reserves theflyonthewall.com -10.51%
10-Jan-14 01:00PM  Midday movers: Target, Blackberry, Pfizer & More at CNBC +10.82%
01:00PM  Midday movers: Target, Blackberry, Pfizer & More
10:16AM  Keep a Close Watch on Synta Pharmaceuticals Corp., Raptor Pharmaceuticals Corp. and AngioDynamics, Inc. Today at Motley Fool
Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs for treating severe medical conditions, including cancer and chronic inflammatory diseases. The company has two drug candidates in clinical trials for treating multiple types of cancer and various drug candidates in the preclinical stage of development. Its lead drug candidate includes ganetespib, an Hsp90 inhibitor, which is in Phase III clinical trial for the treatment of non-small cell lung cancer; in Phase II clinical trial for patients with hormone receptor positive metastatic breast cancer; in Phase I clinical trial for the treatment of HER2 positive patients with metastatic breast cancer; in Phase II/III clinical trial for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome; and in Phase I/II trial of paclitaxel in combination with ganetespib in patients with platinum-resistant ovarian cancer. The company's product pipeline also comprises Hsp90-inhibitor Drug Conjugate, a novel, proprietary small molecule cancer drug development program; and Elesclomol, a mitochondria-targeting agent that is in Phase 2 clinical trial for ovarian cancer. Its product pipeline in preclinical development stage for inflammatory diseases includes CRACM ion channel inhibitors for rheumatoid arthritis, asthma, chronic obstructive pulmonary disease, allergy, transplant rejection, and other autoimmune diseases and inflammatory conditions; and IL-12/23 inhibitors for inflammatory and autoimmune diseases. Synta Pharmaceuticals Corp. was incorporated in 2000 and is based in Lexington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kovner BruceDirectorApr 11Buy4.011,250,0005,012,5008,121,467Apr 14 07:34 PM
Bahcall Safi RPresident and CEONov 13Buy3.7520,00075,0002,053,135Nov 15 06:03 PM
REARDON WILLIAM SDirectorNov 13Buy3.7513,33349,99936,561Nov 15 06:01 PM
Gollust Keith RDirectorNov 13Buy3.75150,000562,5002,823,383Nov 15 05:58 PM
Kovner BruceDirectorNov 13Buy3.755,000,00018,750,0007,649,803Nov 15 05:56 PM